Researchers: Prostate Cancer Deaths Lower for Men Taking Statin Drugs
Prostate cancer is one of the many disabling conditions where both the disease and the course of treatment may impair a patient to where he can no longer work. A new study found that risk of death from prostate cancer may be lower in men who were taking statin drugs prior to diagnosis.
Statin drugs are prescribed for lowering cholesterol and researchers from the Fred Hutchinson Cancer Research Center followed 1,000 men who were diagnosed with prostate cancer between 2002 and 2005 – about 30 percent of whom currently or previously used statin drugs. The 8-year average follow up found that the risk of dying was one percent among the statin drug users and five percent for non-statin users.
Statin drugs are not used as a treatment or preventative measure against prostate cancer and researchers agree that much more information needs to be gathered before trials can begin to determine if the drugs could potentially take up such a role. Meanwhile, prostate cancer remains one of the major causes of disability due to cancer in American men.
The American Cancer Society estimates that in 2013 nearly 240,000 men will be diagnosed with prostate cancer and about 30,000 will die from the disease. It is the second leading cause of cancer death in men after lung cancer. Even with the high number of cases, most men do not die from prostate cancer. More than 2.5 million men in the U.S. who were diagnosed with this disease are still living.
When conditions such as prostate cancer require treatment that causes disabling conditions you may be facing long-term disability. Chemotherapy is a common treatment which can result in extreme fatigue, nausea, and susceptibility to other illnesses.
A disability representative from Disability Help Group can help explore options for disability benefits to help ease the cost of care when you can no longer work. Call today – 1-(800)-800-3332.